Copied to clipboard!
Multimodal analysis of rare BARD1 missense variant
This project analyzes whole-exome sequencing data from a patient with breast cancer recurrence and endometrial cancer, as well as from the patient’s father’s colon tumor, all harboring a rare germline BARD1 missense variant (p.Gly753Val). The data reveal loss of heterozygosity and homologous recombination deficiency specific to the triple-negative breast cancer recurrence, supporting the variant’s conditional pathogenicity linked to prior treatment.
- Type: Exome Sequencing
- Archive: European Genome-phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD50000002412 | Illumina NovaSeq 6000 | 6 |
| Publications | Citations |
|---|---|
|
Multimodal analysis of a rare BARD1 missense variant suggests its pathogenicity is conditional.
NPJ Breast Cancer 12: 2026 86 |
0 |
